The mission of the Small Molecule Drug Development Shared Resource (SR) is to optimize robust assays in 384-well format and to screen large chemical libraries to identify new small molecules for innovative cancer therapeutics.
|Initial consultation||None||Investigators receive feedback regarding assay development/HTS goals, while Director and Managing Director suggest optimal assay approaches|
|Facility orientation/training||$200/ session||2-hr session covering all instruments|
|Operetta microscope, hourly usage||$40/hour||Enables investigators to benefit from automated|
|Managing Director support||$100/hour||General support in assay development and execution|
|Bioactives Library access (3,200 cpds)||$200||Enables pilot screening|
|HTS Library access (50,000 molecules)||$2,000||Enables HTS|
|All-inclusive screening packages||Quotes available||Enables dedicated % effort from Managing Director, library access, and equipment time. Can include reagent costs. Priced on a per-project basis due to varying assay needs.|
Remember to acknowledge the valuable services provided by Cancer Center Shared Resources in your research papers and publications:
"This research was supported by the Small Molecule Drug Development Shared Resource of the Case Comprehensive Cancer Center (P30CA043703)."
Contact for More Information
|Director||Drew Adams, PhD
|Managing Director||Yuriy Fedorov, PhD